HMGCR and pancreatic neoplasm: Deng et al. found that the Wnt/β-catenin signaling pathway accelerated the progression of pancreatic cancer by directly activating the expression of enzymes (e.g., HMGCR and HMGCS) related to mevalonate metabolism [30].